Can HRT protect against colds and flu in menopause? new study investigates

NCT ID NCT07292857

Recruiting now Knowledge-focused Sponsor: Insel Gruppe AG, University Hospital Bern Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study follows 400 women aged 40-60 to compare respiratory infection rates between those taking hormone replacement therapy (HRT) and those not. Participants wear a smartwatch to track vital signs and report symptoms for six months. The goal is to understand if HRT influences infection risk and to develop a wearable-based early warning system for respiratory infections.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help identify whether HRT lowers or raises the risk of respiratory infections in menopausal women and lead to a wearable early-warning system for infections.
What could go wrong: This is an observational study, not a treatment trial, so it cannot prove cause and effect. Results may not apply to all women, and the wearable prediction model may not work as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MENOPAUSAL WOMEN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

respiratory tract infectious disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MENOPAUSAL WOMEN RESPIRATORY TRACT INFECTIONS (RTI)

Contacts and locations

Locations

University Hospital of Bern, Department of Gynecological Endocrinology & Reproductive Medicine
RECRUITING

Bern, 3010, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.